Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: New Constructs, LLC
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Omnicare Inc reaffirms FY 2014 guidance - Conference Call


Wednesday, 23 Jul 2014 09:00am EDT 

Omnicare Inc:Continues to expect FY 2014 net sales between $6.3 billion and $6.4 billion.Continue to expect FY 2014 adjusted cash earnings per diluted share from continuing operations to be $3.64 to $3.72.FY 2014 revenue of $6.4 billion and EPS of $3.69 - Thomson Reuters I/B/E/S. 

Company Quote

64.23
1.14 +1.81%
21 Oct 2014